{
    "nct_id": "NCT05919108",
    "official_title": "Neoadjuvant Neratinib in Stage I-III HER2-Mutated Lobular Breast Cancers",
    "brief_title": "Neoadjuvant Neratinib in Stage I-III HER2-Mutated Lobular Breast Cancers",
    "cancer_type_display": "A study for patients with Stage I-III, HER2-mutated, invasive lobular breast cancer.",
    "cancer_tags": [
      "Anatomic Stage I Breast Cancer",
      "Anatomic Stage II Breast Cancer",
      "Anatomic Stage III Breast Cancer",
      "Invasive Breast Lobular Carcinoma"
    ],
    "link_to_trial": "https://clinicaltrials.gov/study/NCT05919108",
    "phase": "Phase 2",
    "recruitment_status": "RECRUITING",
    "last_update_date": "2025-09-09",
    "enrollment": 30,
    "min_age": 18,
    "max_age": null,
    "sex": "ALL",
    "is_metastatic_allowed": false,
    "performance_status_scale": "ECOG",
    "performance_status_values": [
      0,
      1
    ],
    "min_prior_lines": null,
    "max_prior_lines": null,
    "prior_treatments_required": null,
    "prior_treatments_excluded": [
      "Prior endocrine therapy for breast cancer within the last 2 years",
      "Any investigational treatment for the current diagnosis of breast cancer"
    ],
    "principal_investigator": "Laura Kennedy, MD, PhD",
    "site_name": "Emory University/ Winship Cancer Institute",
    "contact_email": "cip@vumc.org",
    "contact_phone": "800-811-8480",
    "locations": [
      {
        "facility": "Emory University/ Winship Cancer Institute",
        "status": "NOT_YET_RECRUITING",
        "city": "Atlanta",
        "state": "Georgia",
        "zip": "30322",
        "country": "United States",
        "contacts": [
          {
            "name": "Kevin Kalinsky, MD",
            "role": "PRINCIPAL_INVESTIGATOR"
          }
        ],
        "geoPoint": {
          "lat": 33.749,
          "lon": -84.38798
        }
      },
      {
        "facility": "University of Pittsburgh Medical Center",
        "status": "NOT_YET_RECRUITING",
        "city": "Pittsburgh",
        "state": "Pennsylvania",
        "zip": "15213",
        "country": "United States",
        "contacts": [
          {
            "name": "Adam Brufsky, MD",
            "role": "PRINCIPAL_INVESTIGATOR"
          }
        ],
        "geoPoint": {
          "lat": 40.44062,
          "lon": -79.99589
        }
      },
      {
        "facility": "Vanderbilt University/Ingram Cancer Center",
        "status": "RECRUITING",
        "city": "Nashville",
        "state": "Tennessee",
        "zip": "37203",
        "country": "United States",
        "contacts": [
          {
            "name": "Vanderbilt-Ingram Service for Timely Access",
            "role": "CONTACT",
            "phone": "800-811-8480",
            "email": "cip@vumc.org"
          },
          {
            "name": "Laura Kennedy, MD, PhD",
            "role": "PRINCIPAL_INVESTIGATOR"
          }
        ],
        "geoPoint": {
          "lat": 36.16589,
          "lon": -86.78444
        }
      },
      {
        "facility": "University of Texas, Southwestern",
        "status": "RECRUITING",
        "city": "Dallas",
        "state": "Texas",
        "zip": "75390",
        "country": "United States",
        "contacts": [
          {
            "name": "Nisha Unni",
            "role": "CONTACT",
            "email": "Nisha.Unni@UTSouthwestern.edu"
          },
          {
            "name": "Carlos Arteaga, MD",
            "role": "SUB_INVESTIGATOR"
          },
          {
            "name": "Nisha Unni, MD",
            "role": "PRINCIPAL_INVESTIGATOR"
          }
        ],
        "geoPoint": {
          "lat": 32.78306,
          "lon": -96.80667
        }
      },
      {
        "facility": "Baylor College of Medicine",
        "status": "NOT_YET_RECRUITING",
        "city": "Houston",
        "state": "Texas",
        "zip": "77030",
        "country": "United States",
        "contacts": [
          {
            "name": "Bora Lim, MD",
            "role": "PRINCIPAL_INVESTIGATOR"
          }
        ],
        "geoPoint": {
          "lat": 29.76328,
          "lon": -95.36327
        }
      }
    ],
    "key_inclusion_summary": [
      "Aged 18 years or older.",
      "New diagnosis of clinical stage I-III HR+ histologically-proven invasive lobular carcinoma.",
      "Previously documented activating HER2 mutation confirmed by a CLIA-certified or equivalent laboratory.",
      "Minimum tumor size of â‰¥1.5 cm.",
      "ECOG performance status of 0 or 1."
    ],
    "key_exclusion_summary": [
      "Evidence of distant metastatic disease.",
      "Synchronous breast cancer that is estrogen receptor negative OR HER2-amplified.",
      "Prior endocrine therapy for breast cancer within the last 2 years.",
      "HER2 amplification by FISH (HER2:CEP17 ratio >2.0) or IHC (HER2 (3+)).",
      "Significant chronic gastrointestinal disorder with diarrhea as a major symptom."
    ]
  }